Young Investigator Awards

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Molecular and immune profiling of acral melanoma from various ethnicities

MRA Young Investigator Award, collaboratively funded by University of Texas MD Anderson Cancer Center, 2018-2021

  • Phyu Aung, University of Texas MD Anderson Cancer Center

Building a predictive framework for vaccine design against melanoma

Elliott and Ruth Sigal-MRA Young Investigator Award, 2018-2021

  • Nicolas Chevrier, The University of Chicago

Manipulating cellular metabolism to promote cancer immunity in melanoma

The Robbins Family-MRA Young Investigator Award, 2018-2021

  • Ku-Lung Hsu, The University of Virginia

Investigating the mechanistic basis for tumor immunogenicity in melanoma

The Sokoloff Family-MRA Young Investigator Award, 2018-2021

  • Nikhil Joshi, Yale University

LncRNAs as modulators of protein synthesis rewiring in melanoma

Amanda and Jonathan Eilian-MRA Young Investigator Award, 2018-2021

  • Eleonora Leucci, Katholieke Universiteit Leuven

Primary anogenital melanoma: Comprehensive molecular and immune analysis

MRA Young Investigator Award, collaboratively funded by University of Texas MD Anderson Cancer Center, 2018-2021

  • Priyadharsini Nagarajan, University of Texas MD Anderson Cancer Center

Isoform-specific targeting of the PI3Ks to overcome cancer immunoresistance

MRA Young Investigator Award, collaboratively funded by University of Texas MD Anderson Cancer Center, 2018-2021

  • Weiyi Peng, University of Texas MD Anderson Cancer Center

Dependence of melanoma metastasis on AMPK-mediated metabolic switch

Ellen and Gary Davis Foundation-MRA Young Investigator Award, collaboratively funded by Joan & Sanford I. Weill Medical College of Cornell University, 2018-2021

  • Elena Piskounova, Joan & Sanford I. Weill Medical College of Cornell University

The genomic landscape of individual melanocytes from human skin

Tara Miller Melanoma Foundation-MRA Young Investigator Award, 2018-2021

  • A. Hunter Shain, The University of California, San Francisco

A novel approach for NF1 mutant melanoma sub-classification

MRA Young Investigator Award, 2018-2021

  • Edward Stites, The Salk Institute for Biological Studies

Targeting PSGL-1 inhibitory pathways to promote anti-tumor T cell immunity

The Denise and Michael Kellen Foundation-MRA Young Investigator Award, 2018-2021

  • Roberto Tinoco, Sanford Burnham Prebys Medical Discovery Institute

Pilot study of intervention to reduce sunburns in melanoma survivors

The Wayne Stinchcomb Big Orange Foundation-MRA Young Investigator Award for Women in Scientific Research, 2018-2021

  • Rachel Vogel, The University of Minnesota – Twin Cities

Targeting the JNK-ITCH signaling pathway in melanoma

Mary Jo and Brian Rogers-MRA Young Investigator Award, 2018-2021

  • Lixin Wan, H. Lee Moffitt Cancer Center & Research Institute

Developing advanced non-invasive histology techniques

Brownstein, Hyatt, Farber & Schreck-MRA Young Investigator Award, 2018-2021

  • Jesse Wilson, Colorado State University

Targeting BRAF/NRAS wildtype melanoma with ERBB3 and MEK Inhibition

Julie and Edward J. Minskoff-MRA Young Investigator Award, collaboratively funded by New York University School of Medicine, 2018-2021

  • Melissa Wilson, New York University School of Medicine

YOU MAY BE INTERESTED IN

Cell and gene therapies have made incredible strides over the past decade. The 2024 FDA approvals of the first T-cell receptor therapy for the treatment of metastatic synovial sarcoma and the first tumor-infiltrating lymphocyte therapy for the treatment of unresectable or metastatic melanoma mark a significant turning point for solid tumor treatment.xxx:more
The intersection of diabetes, obesity and cancer represents an important and underappreciated challenge in medicine. Apart from smoking, overweight is now the leading modifiable risk factor for cancer. With the global epidemic of overweight and diabetes driving cancer incidence across multiple organ sites, understanding the metabolic underpinnings of this relationship has never been more critical.
The Pazdurs in their garden with their dog, Cleo. The dog’s full name is Cleopatra, Queen of Denial.In 1999, Rick Pazdur went in for a “perfunctory” final interview at FDA. Thinking it would only take a few minutes, his wife, Mary, decided to wait and have a quick cup of coffee at a nearby restaurant—Hooters.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login